Company profile
UK company 12766216, incorporated on 24 July 2020.
Homepage - GlycoScoreDx
Introducing the GlycoScore Prostate Cancer Test, a simpleblood test enabling accurate early detection of aggressiveprostate cancer
Company number 12766216
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
GlycoScoreDx develops new methods of testing for prostate cancer.
GlycoScoreDx Ltd is a new spin-out company originating from Newcastle University. The company was established in 2021 after receiving seed funding from Innovate UK (£210,000, plus matched private investment funding) to support establishment of the business and the commercial development of the GlycoScore test. GlycoScoreDx's vision is to provide superior cancer diagnostics, using simple to use detection methods that require no capital investment for the customer. The business is founded on more than a decade of research in the area of glycosylation and cancer, undertaken by Dr Jennifer Munkley and her team, which led to the discovery of the GlycoScore test. The company aims to provide innovative new diagnostics that are based on understanding the fundamental pathology of disease rather than variable expression of different markers. GlycoScore can be used in different ways for diagnosing prostate cancer, including initial diagnosis, prognosis and active surveillance.
The care pathway analysis and health economic modelling proposed in this study will provide invaluable information for the design of the clinical utility study and future clinical adoption. In addition to GlycoScore, the company has an innovation team that are validating a new diagnostic for pancreatic cancer, which will be the second product in our portfolio.
1 Apr 2021 to 31 Aug 2022
In the UK, one in eight men will get prostate cancer within their lifetime. The prostate is a gland only men have, which helps makes semen. As men get older the prostate can become larger. In many cases this change is normal, however it can be an early sign of prostate cancer. Prostate cancer develops when cells in the prostate gland grow in an uncontroll...
